Specifically, the Human Protein Atlas reports that 8 out of 12 human colorectal cancers demonstrate reduced intensity of immunostaining for PDE4B antigen in the epithelial component of these cancers, compared to samples from the normal colon and rectum [19]. The gene discussed is PDE4B; the disease is colorectal cancer.